Skip to main content
. 2022 Jun 1;17(6):e0269245. doi: 10.1371/journal.pone.0269245

Fig 3. Cumulative incidences of health outcomes by the four HbA1c trajectories.

Fig 3

(A) Cumulative incidence of death since T2D diagnosis. (B) Cumulative incidence of combined event of micro- and macrovascular complications since T2D diagnosis.